Lung Cancer Genomic Signatures

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Thoracic Oncology

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/JTO.0b013e3181f1900ePMID 20736853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• A dictionary on microRNAs and their putative target pathways

  2010cited by this paper
• Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor

  2010cited by this paper
• Targeting the transforming growth factor-beta signalling pathway in metastatic cancer.

  2010cited by this paper
• Epigenetics in cancer.

  2010cited by this paper
• TGF-&bgr; Signaling and the Role of Inhibitory Smads in Non-small Cell Lung Cancer

  2010cited by this paper
• Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma

  2009cited by this paper
• Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.

  2009cited by this paper
• Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.

  2009cited by this paper
• Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

  2009cited by this paper
• An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma

  2009cited by this paper
• An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer

  2009cited by this paper
• Prognostic gene signatures for non-small-cell lung cancer

  2009cited by this paper
• MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.

  2009cited by this paper
• ErbBs in lung cancer.

  2009cited by this paper
• MicroRNAs: novel biomarkers for human cancer.

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.

  2009cited by this paper
• Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes.

  2009cited by this paper
• Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.

  2009cited by this paper
• A Four-Gene Signature from NCI-60 Cell Line for Survival Prediction in Non–Small Cell Lung Cancer

  2009cited by this paper
• Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.

  2008cited by this paper
• Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model

  2008cited by this paper
• Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

  2008cited by this paper
• Expression signatures in lung cancer reveal a profile for EGFR‐mutant tumours and identify selective PIK3CA overexpression by gene amplification

  2008cited by this paper
• SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells.

  2008cited by this paper
• MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression

  2008cited by this paper
• Lung adenocarcinoma invasion in TGFβRII-deficient cells is mediated by CCL5/RANTES

  2008cited by this paper
• Analysis of gene expression in a developmental context emphasizes distinct biological leitmotifs in human cancers

  2008cited by this paper
• An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer

  2008cited by this paper
• Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours

  2008cited by this paper
• A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25

  2008cited by this paper
• A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

  2008cited by this paper
• Somatic mutations affect key pathways in lung adenocarcinoma

  2008cited by this paper
• Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype

  2008cited by this paper
• Epigenetics in cancer.

  2008cited by this paper
• MicroRNAs accurately identify cancer tissue origin

  2008cited by this paper
• A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma

  2008cited by this paper
• MicroRNA: an Emerging Therapeutic Target and Intervention Tool

  2008cited by this paper
• Genetic variants of miRNA sequences and non-small cell lung cancer survival.

  2008cited by this paper
• MicroRNA signature predicts survival and relapse in lung cancer.

  2008cited by this paper
• Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice

  2008cited by this paper
• Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival

  2008cited by this paper
• Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer

  2008cited by this paper
• A six-gene signature predicting breast cancer lung metastasis.

  2008cited by this paper
• Toward the individualization of lung cancer therapy

  2008cited by this paper
• Germline Polymorphisms in EGFR and Survival in Patients With Lung Cancer Receiving Gefitinib

  2008cited by this paper
• Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis

  2008cited by this paper
• Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung Cancer

  2008cited by this paper
• Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours

  2008cited by this paper
• A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism.

  2008cited by this paper
• NOVEL AGENTS IN THE TREATMENT OF LUNG CANCER Summary Statement Novel Agents in the Treatment of Lung Cancer : Fifth Cambridge Conference Assessing Opportunities for Combination Therapy

  2008cited by this paper
• VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.

  2008cited by this paper
• Oncomirs: The potential role of non-coding microRNAs in understanding cancer

  2008cited by this paper
• Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib

  2008cited by this paper
• A Phase II Pharmacodynamic Study of Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy

  2008cited by this paper
• Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung

  2008cited by this paper
• Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

  2008cited by this paper
• A five-gene signature and clinical outcome in non-small-cell lung cancer.

  2007cited by this paper
• Cross-study validation and combined analysis of gene expression microarray data.

  2007cited by this paper
• Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

  2007cited by this paper
• Survival prediction of stage I lung adenocarcinomas by expression of 10 genes.

  2007cited by this paper
• EGFR, HER2 and VEGF pathways: validated targets for cancer treatment.

  2007cited by this paper
• BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer

  2007cited by this paper
• Expression profiling of genes regulated by TGF-beta: Differential regulation in normal and tumour cells

  2007cited by this paper
• Tumor mRNA expression profiles predict responses to chemotherapy.

  2007cited by this paper
• Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.

  2007cited by this paper
• Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

  2007cited by this paper
• Novel Agents in the Treatment of Lung Cancer: Fourth Cambridge Conference

  2007cited by this paper
• Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

  2007cited by this paper
• Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest

  2007cited by this paper
• Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting.

  2007cited by this paper
• Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.

  2007cited by this paper
• MicroRNA genes are frequently located near mouse cancer susceptibility loci

  2007cited by this paper
• Mining gene expression profiles: expression signatures as cancer phenotypes

  2007cited by this paper
• Characterizing the cancer genome in lung adenocarcinoma

  2007cited by this paper
• microRNAs as oncogenes and tumor suppressors.

  2007cited by this paper
• Neurological Disorders: Public Health Challenges

  2007cited by this paper
• The evolution of gene regulation by transcription factors and microRNAs

  2007cited by this paper
• Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma

  2007cited by this paper
• Three-gene prognostic classifier for early-stage non small-cell lung cancer.

  2007cited by this paper
• Impaired microRNA processing enhances cellular transformation and tumorigenesis

  2007cited by this paper
• The let-7 microRNA represses cell proliferation pathways in human cells.

  2007cited by this paper
• MicroRNA—implications for cancer

  2007cited by this paper
• Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer.

  2007cited by this paper
• Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

  2007cited by this paper
• Interpretation of microarray data in cancer

  2007cited by this paper
• Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.

  2007cited by this paper
• The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

  2007cited by this paper
• MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.

  2007cited by this paper
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

  2007cited by this paper
• Molecular concepts analysis links tumors, pathways, mechanisms, and drugs.

  2007cited by this paper
• Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells

  2007cited by this paper
• MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

  2007cited by this paper
• How could pharmacogenomics help improve patient survival?

  2007cited by this paper
• Molecular signatures of lung cancer--toward personalized therapy.

  2007cited by this paper
• Genomic signatures to guide the use of chemotherapeutics

  2006cited by this paper
• Baseline Gene Expression Predicts Sensitivity to Gefitinib in Non–Small Cell Lung Cancer Cell Lines

  2006cited by this paper
• Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper

• Lack of imbalance between the master regulators TTF1/NKX2-1 and ΔNp63/p40 implies adverse prognosis in non-small cell lung cancer

  2024cites this paper
• The Use of Isoflavones as Lung Cancer Chemoprevention Agents and their Implications in Treatment through Radio Sensitization.

  2024cites this paper
• Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer.

  2022cites this paper
• Bioinformatics Analyses Reveals a Comprehensive Landscape of CXC Chemokine Family Functions in Non-Small Cell Lung Cancer

  2021cites this paper
• The safety and efficacy of neoadjuvant programmed death 1 inhibitor therapy with surgical resection in stage IIIA non-small cell lung cancer

  2021cites this paper
• HOXA10 promotion of HDAC1 underpins the development of lung adenocarcinoma through the DNMT1-KLF4 axis

  2021cites this paper
• Pemetrexed en cáncer de pulmón no microcítico en estadíos avanzado o metastásico: efectividad, seguridad y perfil de utilización en hospitales del sistema sanitario público de Andalucía

  2017cites this paper
• Ornithine decarboxylase gene expression and activity in lung cancer

  2016cites this paper
• A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer

  2015cites this paper
• Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes.

  2015cites this paper
• Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer.

  2015cites this paper
• 基于蛋白质组学的肺癌生物标志物研究进展

  2015cites this paper
• Systematic review of efficacy and safety of pemetrexed in non-small-cell-lung cancer

  2014cites this paper
• Proteomic characterization of lung cancer and chronic obstructive pulmonary disease: a bronchoalveolar lavage fluid analysis

  2014cites this paper
• Identifying differentially expressed genes and pathways in two types of non-small cell lung cancer: adenocarcinoma and squamous cell carcinoma.

  2014cites this paper
• Association between single nucleotide polymorphism of PD‐L1 gene and non‐small cell lung cancer susceptibility in a Chinese population

  2014cites this paper
• RNA sequencing identifies novel markers of non-small cell lung cancer.

  2014cites this paper
• Genome-wide transcriptional analysis of apoptosis-related genes and pathways regulated by H2AX in lung cancer A549 cells

  2013cites this paper
• Translating metastasis-related biomarkers to the clinic—progress and pitfalls

  2013cites this paper
• RET融合基因在非小细胞肺癌诊治中的意义

  2013cites this paper
• Proteomic biomarkers in lung cancer

  2013cites this paper
• Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors

  2013cites this paper
• Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber.

  2012cites this paper
• 5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis

  2012cites this paper
• Ribonucleic acid microarray analysis from lymph node samples obtained by endobronchial ultrasonography-guided transbronchial needle aspiration.

  2012cites this paper
• Molecular Characterisation and Prognostic Biomarker Discovery in Human Non-Small Cell Lung Cancer

  2012cites this paper
• Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.

  2012cites this paper
• TITLE: Molecular Profiles for Lung Cancer Pathogenesis and Detection in US Veterans

  2011cites this paper
• Molecular Profiles for Lung Cancer Pathogenesis and Detection in U.S. Veterans

  2011cites this paper
• Evolving concepts in lung carcinogenesis.

  2011cites this paper
• Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer

  2011cites this paper
• Evolving Concepts in Lung Carcinogenesis

  2011cites this paper
• NSCLC : integrated genomic database of non-small cell lung cancer

  2011cites this paper
• IGDB.NSCLC: integrated genomic database of non-small cell lung cancer

  2011cites this paper